Status:

COMPLETED

Bee Venom Phonophoresis on Mild to Moderate Localized Plaque Psoriasis on Knee Joint

Lead Sponsor:

MTI University

Conditions:

Plaque Psoriasis

Eligibility:

All Genders

20-50 years

Phase:

NA

Brief Summary

Chronic plaque psoriasis, or psoriasis vulgaris, is a chronic inflammatory skin disease characterized by well demarcated, erythematous, scaly plaques on the extensor surfaces of the body and scalp. Th...

Detailed Description

Apitherapy is an alternate therapy that relies on the usage of honeybee products, most importantly bee venom for the treatment of many human diseases. The venom can be introduced into the human body b...

Eligibility Criteria

Inclusion

  • Inclusion criteria
  • Symmetrical mild-to-moderate chronic plaque psoriasis
  • Chronic stable plaque psoriasis
  • Bilateral lesions of approximately 25 cm²
  • Had not been receiving any treatment for at least one month.
  • Those with infection or malignancy and/or subjects who had undergone major surgery in the past 6 months were not included in the study.
  • Patients that had not undergone systemic treatment for psoriasis during the previous 3 months were included in the study
  • age 20 - 50 with mild to moderate knee plaque psoriasis
  • Symmetrical plaque psoriasis
  • PASI score affected \< 20
  • BSA of knee involvement : 2% to 20%
  • Exclusion criteria
  • Patients with malignant tumors, those diagnosed with psoriatic arthritis or any other systemic inflammatory disease, or those using medication were excluded from the study.
  • Pregnancy
  • Receiving steroid preparations
  • topical or UVB therapy within previous 4 wks
  • Systemic corticosteroids, PUVA, or laser phototherapy within previous 4 wks
  • Other systemic therapies or biologicals within previous 3 wks
  • Widespread psoriasis
  • Hypercalcaemia
  • Liver or renal disease

Exclusion

    Key Trial Info

    Start Date :

    January 1 2024

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    April 15 2024

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT06106230

    Start Date

    January 1 2024

    End Date

    April 15 2024

    Last Update

    April 17 2024

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Ahmed Mohamed Ahmed Abdelhady

    Cairo, Egypt, 11571